The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have launched a call for evidence to evaluate the impact of resources developed under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and is scheduled to remain open until 26 February 2027.
The agencies are seeking feedback from a broad group of stakeholders. These include developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers, regulators, people with lived experience of mental health conditions, carers and members of the public.
Phase 1 evaluation
According to the MHRA and NICE, the survey is part of the programme’s Phase 1 evaluation. It aims to assess how the resources have been received and used across the sector. The organisations said they are particularly interested in understanding whether the materials have influenced users’ knowledge, confidence, decision-making and professional practice.
The resources were developed to support the safe development, regulation, evaluation and adoption of digital mental health technologies, including mental health apps and other digital tools.
Informing Phase 2
Findings from the survey will help determine whether the Phase 1 outputs have achieved their intended objectives. They will also inform the future direction of Phase 2 of the DMHT programme.
The MHRA and NICE encouraged stakeholders to take part regardless of whether they have engaged extensively, minimally or not at all with the existing resources. The agencies said the feedback will help identify strengths, highlight areas for improvement and shape future work intended to improve the safety and effectiveness of digital mental health technologies.